Diagnostic Approach to Migratory Polyarthritis

Initial Diagnostic Steps

When a patient presents with migratory polyarthritis and a positive rheumatoid factor, ultrasound or MRI of affected joints should be performed as the next diagnostic step to accurately assess inflammation and guide diagnosis, as recommended by the European League Against Rheumatism 1
The American College of Rheumatology suggests that after identifying migratory polyarthritis with positive RF, the following laboratory tests should be performed: Anti-citrullinated protein/peptide antibodies (ACPA) - Critical for confirming RA diagnosis and has higher specificity than RF, and ESR and CRP - Should be measured at baseline for both diagnosis and prognosis 2

ACPA testing is critical for confirming RA diagnosis and has higher specificity than RF, according to the European League Against Rheumatism 2
ESR and CRP should be measured at baseline for both diagnosis and prognosis, as recommended by the American College of Rheumatology 2
Additional autoantibody tests, such as Antinuclear antibodies (ANA), Anti-extractable nuclear antigens, and Anti-double-stranded DNA, may be considered if connective tissue disease is suspected, as suggested by the European League Against Rheumatism 2

X-rays of affected joints should be performed at baseline, and repeated within 1 year, to assess for erosions and predict RA development and disease persistence, as recommended by the American College of Rheumatology 2
Ultrasound or MRI of affected joints is superior to clinical examination for detecting inflammation, and can detect synovitis, bone edema, and erosions that predict progression to RA, according to the European League Against Rheumatism 1
MRI of hands and wrists should be considered when RA is suspected, as suggested by the American College of Rheumatology 2

Confirm inflammatory arthritis by documenting predictors of persistent inflammatory arthritis, such as disease duration ≥6 weeks, morning stiffness >30 minutes, functional impairment, small joint involvement, involvement of ≥3 joints, RF and/or ACPA positivity, and radiographic erosions, as recommended by the European League Against Rheumatism 2
Rule out differential diagnoses, such as autoimmune, infectious, malignancy, metabolic, etc., and consider HLA-B27 testing and synovial biopsy in specific clinical settings, as suggested by the American College of Rheumatology 2

Regular assessment of disease activity is essential, although no specific tool is universally recommended, according to the European League Against Rheumatism 2
Overlooking pre-treatment with NSAIDs may mask the classic migratory pattern of arthritis, as noted by the American Heart Association 3
Failing to exclude other causes, such as septic arthritis, crystal arthropathies, viral arthritis, and other inflammatory conditions, can lead to delayed or incorrect diagnosis, as warned by the American Society of Clinical Oncology 4